Home › Funds › First Eagle Investment Management › EXEL
First Eagle Investment Management position in EXEL
EXELIXIS INC · Health Care
Latest position (Q2 2026)10.00K sh
Reported value held$544.10K
Portfolio Weight0.00%
First reportedQ3 2023
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 25.20K | $550.51K | New |
| Q4 2023 | 25.20K | $604.43K | Hold |
| Q1 2024 | 14.79K | $350.90K | Reduce |
| Q2 2024 | 15.89K | $356.98K | Add |
| Q3 2024 | 17.49K | $453.79K | Add |
| Q4 2024 | 18.69K | $622.28K | Add |
| Q1 2025 | 19.69K | $726.84K | Add |
| Q2 2025 | 20.68K | $911.60K | Add |
| Q3 2025 | 16.27K | $671.99K | Reduce |
| Q4 2025 | 12.57K | $550.99K | Reduce |
| Q1 2026 | 10.00K | $428.90K | Reduce |
| Q2 2026 | 10.00K | $544.10K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding EXEL
- BlackRock Inc 29.08M sh · $1.58B · Q2 2026
- Vanguard Group 25.49M sh · $1.12B · Q4 2025
- Farallon Capital Management 13.47M sh · $732.79M · Q2 2026
- Renaissance Technologies 13.43M sh · $730.62M · Q2 2026
- AQR Capital Management 11.02M sh · $598.60M · Q2 2026
- Geode Capital Management 7.65M sh · $416.32M · Q2 2026
- D. E. Shaw & Co 5.55M sh · $302.07M · Q2 2026
- Morgan Stanley 4.52M sh · $245.92M · Q2 2026
- Invesco Ltd 4.50M sh · $244.61M · Q2 2026
- Arrowstreet Capital 4.37M sh · $237.55M · Q2 2026
- Two Sigma Investments 4.21M sh · $229.06M · Q2 2026
- UBS Group AG 3.17M sh · $172.36M · Q2 2026